NACE 46.46 in FR. Official registry identity, company-size evidence and a rounded indicative valuation range on one indexed company profile.
Historical indicative ranges based on public filings. This is not an asking price or confirmation that the company is for sale.
Based on official company-size informationCreate a free account to see the detailed curve, the factors that influence it, and an indicative five-year outlook.
Free account · private workspace
You have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
This company is not currently listed for sale on Upswitch.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Operating as a business in NACE sector 46.46, PROXIPHARM is registered in France. The company was founded in 2026, incorporated as a 5710.
PROXIPHARM is listed in French National Business Register (RNE/INPI) under registry number 100777515.
Companies in this NACE 46.46 band file annual accounts with INPI.
PROXIPHARM's public range combines official company-size information with sector multiples. It remains indicative and is not a midpoint, sale price, offer, or recommendation.
The range is refreshed when the official size or registry source for PROXIPHARM changes.
PROXIPHARM was founded in 2026 and is registered with French National Business Register (RNE/INPI), incorporated as a 5710.
PROXIPHARM is registered under NACE 46.46: NACE 46.46. That places the business within the French cluster for this activity.
This page shows a rounded, automated indicative range generated by Upswitch from official registry facts, public company-size information, filed accounts where available, and governed sector benchmarks. The evidence basis is labelled beside the graph. It is not a certified or statutory valuation, sale price, offer, recommendation, or financial, investment, tax or legal advice. Figures for PROXIPHARM may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
